Studies investigating long-distance intercellular miRNA communication
Authors . | Analyzed aspect . | Cells/cell lines . | transported miRNAs . | Methods . | Reference . |
---|---|---|---|---|---|
Yuan et al, 2009 | Transfer of miRNAs by embryonic stem cell microvesicles | Murine ES cells | miR-290 | Coculture, qRT-PCR, visual confirmation of GFP-labeled MV uptake | 60 |
MEFs | miR-291-3p | ||||
miR-292-3p | |||||
miR-294, -295 | |||||
Zhang et al, 2010 | Influence of secreted monocytic miR-150 on endothelial cell migration | THP-1 primary PBMCs | miR-150 and 26 others | Endothelial cell migration and various reporter assays, quantification of miRNA target via western blot | 24 |
HMEC-1 | |||||
Collino et al, 2010 | miRNA content of MSC and HLSC vesicles | Primary MSCs and HLSCs | miR-21, -451, | qRT-PCR of producer cells, MVs, and target cells; visual confirmation of MV and miRNA uptake, quantification of miRNA targets | 70 |
mTEC | miR-100, -99a | ||||
miR-223, -564 | |||||
Vickers et al, 2011 | Cellular export and uptake of functional HDL-bound miRNAs | Huh7, HEK293, J774, BHK cells, human plasma | miR-135a* | miRNA microarray and luciferase reporter assays, loss/gain of function studies | 19 |
miR-188-5p | |||||
miR-877, -223 | |||||
Grange et al, 2011 | Exchange of genetic information between tumor and stromal cells | HUVECs | miR-29a/c, -19b, | MV treatment of SCID mice, in vitro + in vivo angiogenesis + metastasis assays, mRNA/miRNA profiling | 71 |
CD105+ cancer stem cells | miR-151, -650, | ||||
miR-200c, -141 | |||||
miR-92 | |||||
Hergenreider et al, 2012 | Atheroprotective communication between endothelial cells and SMCs through miRNAs | HUVECs | miR-143 | Coculture and reporter assays, qRT-PCR, injection of MVs into ApoE-/- mice + readout, antagomiR experiments | 72 |
HAECs | miR-145 | ||||
HASMCs | |||||
Umezu et al, 2012 | Leukemia cell to endothelial cell communication via exosomal miRNAs | K562 | miR-92a | Coculture and reporter assays, miRNA expression profiling | 67 |
HUVECs | |||||
Fonsato et al, 2012 | Antitumor effect of miRNA-containing vesicles on hepatoma cells | HLSCs | miR-451 | Intratumor injection of miRNA and miRNA inhibitor–containing MVs into SCID mice | 73 |
HepG2 | miR-223 | ||||
Primary hepatoma | miR-24 | ||||
miR-31 | |||||
Xin et al, 2012 | Communication between MSCs and neural cells via exosomal miRNAs | Primary rat MSCs, neurons, and astrocytes | miR-133b | Coculture, knockdown, and luciferase reporter assays, in vitro treatment of neurons with MVs | 74 |
Ismail et al, 2013 | Transport of macrophage-derived MVs to target cells | Primary PBMCs | miR-223 | AntagomiR transfection, fluorescent MV labeling + microscopy, luciferase reporter assay, qRT-PCR | 75 |
THP-1 | |||||
CCL-204 | |||||
A549 | |||||
Cantaluppi et al, 2012 | miRNA-containing MVs released by endothelial cells preventing kidney injury | Primary PBMCs | miR-126 | Injection of MVs into rats following IRI (also Dicer knocked-down/antagomiR MV application) | 76 |
TepCs | miR-296 | ||||
Montecalvo et al, 2012 | Transfer of functional miRNAs between murine DCs via exosomes | Murine BM-derived DCs and 1H3.1 and OT-II T cells | miR-451, miR148a | Fluorescence- and microscopy-based analysis of MV uptake and cytosolic content release, miRNA profiling + reporter assays | 77 |
Katsman et al, 2012 | Effect of ES cell MVs on retinal progenitor cells | Murine ES cells | miR-292 | qRT-PCR | 78 |
MIO-M1 | miR-295 |
Authors . | Analyzed aspect . | Cells/cell lines . | transported miRNAs . | Methods . | Reference . |
---|---|---|---|---|---|
Yuan et al, 2009 | Transfer of miRNAs by embryonic stem cell microvesicles | Murine ES cells | miR-290 | Coculture, qRT-PCR, visual confirmation of GFP-labeled MV uptake | 60 |
MEFs | miR-291-3p | ||||
miR-292-3p | |||||
miR-294, -295 | |||||
Zhang et al, 2010 | Influence of secreted monocytic miR-150 on endothelial cell migration | THP-1 primary PBMCs | miR-150 and 26 others | Endothelial cell migration and various reporter assays, quantification of miRNA target via western blot | 24 |
HMEC-1 | |||||
Collino et al, 2010 | miRNA content of MSC and HLSC vesicles | Primary MSCs and HLSCs | miR-21, -451, | qRT-PCR of producer cells, MVs, and target cells; visual confirmation of MV and miRNA uptake, quantification of miRNA targets | 70 |
mTEC | miR-100, -99a | ||||
miR-223, -564 | |||||
Vickers et al, 2011 | Cellular export and uptake of functional HDL-bound miRNAs | Huh7, HEK293, J774, BHK cells, human plasma | miR-135a* | miRNA microarray and luciferase reporter assays, loss/gain of function studies | 19 |
miR-188-5p | |||||
miR-877, -223 | |||||
Grange et al, 2011 | Exchange of genetic information between tumor and stromal cells | HUVECs | miR-29a/c, -19b, | MV treatment of SCID mice, in vitro + in vivo angiogenesis + metastasis assays, mRNA/miRNA profiling | 71 |
CD105+ cancer stem cells | miR-151, -650, | ||||
miR-200c, -141 | |||||
miR-92 | |||||
Hergenreider et al, 2012 | Atheroprotective communication between endothelial cells and SMCs through miRNAs | HUVECs | miR-143 | Coculture and reporter assays, qRT-PCR, injection of MVs into ApoE-/- mice + readout, antagomiR experiments | 72 |
HAECs | miR-145 | ||||
HASMCs | |||||
Umezu et al, 2012 | Leukemia cell to endothelial cell communication via exosomal miRNAs | K562 | miR-92a | Coculture and reporter assays, miRNA expression profiling | 67 |
HUVECs | |||||
Fonsato et al, 2012 | Antitumor effect of miRNA-containing vesicles on hepatoma cells | HLSCs | miR-451 | Intratumor injection of miRNA and miRNA inhibitor–containing MVs into SCID mice | 73 |
HepG2 | miR-223 | ||||
Primary hepatoma | miR-24 | ||||
miR-31 | |||||
Xin et al, 2012 | Communication between MSCs and neural cells via exosomal miRNAs | Primary rat MSCs, neurons, and astrocytes | miR-133b | Coculture, knockdown, and luciferase reporter assays, in vitro treatment of neurons with MVs | 74 |
Ismail et al, 2013 | Transport of macrophage-derived MVs to target cells | Primary PBMCs | miR-223 | AntagomiR transfection, fluorescent MV labeling + microscopy, luciferase reporter assay, qRT-PCR | 75 |
THP-1 | |||||
CCL-204 | |||||
A549 | |||||
Cantaluppi et al, 2012 | miRNA-containing MVs released by endothelial cells preventing kidney injury | Primary PBMCs | miR-126 | Injection of MVs into rats following IRI (also Dicer knocked-down/antagomiR MV application) | 76 |
TepCs | miR-296 | ||||
Montecalvo et al, 2012 | Transfer of functional miRNAs between murine DCs via exosomes | Murine BM-derived DCs and 1H3.1 and OT-II T cells | miR-451, miR148a | Fluorescence- and microscopy-based analysis of MV uptake and cytosolic content release, miRNA profiling + reporter assays | 77 |
Katsman et al, 2012 | Effect of ES cell MVs on retinal progenitor cells | Murine ES cells | miR-292 | qRT-PCR | 78 |
MIO-M1 | miR-295 |
BM, bone marrow; DC, dendritic cell; IRI, renal ischemia-reperfusion injury; MSC, mesenchymal stem cell; MV, microvesicle; PBMC, peripheral blood mononuclear cell; SCID, severe combined immunodeficiency; GFP, green fluorescent protein.